The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Weekly cisplatin versus standard three-weekly cisplatin in concurrent chemoradiotherapy of head and neck cancer: Baskent University experience.
F. Kose
No relevant relationships to disclose
A. A. Besen
No relevant relationships to disclose
A. T. Sümbül
No relevant relationships to disclose
A. Sezer
No relevant relationships to disclose
C. Karadeniz
No relevant relationships to disclose
U. Disel
No relevant relationships to disclose
O. Altundag
No relevant relationships to disclose
O. Ozyilkan
No relevant relationships to disclose